- Home
- RMM vs RXST Comparison
RMM vs RXST Comparison
Compare RMM & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMM | RXST |
|---|---|---|
| Founded | N/A | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.0M | 300.5M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RMM | RXST |
|---|---|---|
| Price | $14.32 | $4.97 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $9.78 |
| AVG Volume (30 Days) | 35.7K | ★ 737.5K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $134,479,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.35 | $4.70 |
| 52 Week High | $14.88 | $15.81 |
Technical Indicators
Market Signals| Indicator | RMM | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 52.83 | 32.88 |
| Support Level | $13.90 | N/A |
| Resistance Level | $14.64 | $7.60 |
| Average True Range (ATR) | 0.20 | 0.32 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 60.29 | 12.57 |
Price Performance
Historical ComparisonAbout RMM RiverNorth Managed Duration Municipal Income Fund Inc.
RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.